Researchers’ Views of the Acceptability of Restrictive Provisions in Clinical Trial Agreements with Industry Sponsors

TitleResearchers’ Views of the Acceptability of Restrictive Provisions in Clinical Trial Agreements with Industry Sponsors
Publication TypeJournal Article
Year of Publication2005
AuthorsMello, M, Clarridge, B, Studdert, D
JournalAccountability in Research: Policies & Quality Assurance
Volume12
Issue3
Pagination163-191
Type of ArticleArticle
Publication Languageeng
ISSN Number08989621
Accession Number18448921
KeywordsAcademic , Clinical , Conflict , Drug , Medical , MEDICINE , publications/standards , research , United , University/Industry Collaboration
AbstractThis study reports the results of a mail survey of 884 U.S. medical school faculty active in clinical research which asked them about their views about the acceptability of provisions in contracts for industry-sponsored clinical trials that would restrict investigators’ academic freedom and control over trials.
NotesMello, Michelle 1; Email Address: mmello@hsph.harvard.edu; Clarridge, Brian 2; Studdert, David 1; Affiliations: 1: Department of Health Policy and Management, Harvard School of Public Health, Boston, MA; 2: Center for Survey Research, University of Massachusetts Boston, Boston, MA; Issue Info: Jul-Sep2005, Vol. 12 Issue 3, p163; Thesaurus Term: RESEARCH; Subject Term: MEDICINE; Subject Term: CLINICAL trials; Subject Term: MEDICAL colleges; Subject Term: ACADEMIC freedom; Subject: UNITED States; Author-Supplied Keyword: conflict of interest; Author-Supplied Keyword: drug industry; Author-Supplied Keyword: publications/standards; Author-Supplied Keyword: research support; NAICS/Industry Codes: 611310 Colleges, Universities, and Professional Schools; NAICS/Industry Codes: 541712 Reseach and Development in the Physical, Engineering, and Life Sciences (except Biotechnology); Number of Pages: 29p; Illustrations: 5 Charts; Document Type: Article
DOI10.1080/08989620500216380
Short TitleResearchers’ Views of the Acceptability of Restrictive Provisions in Clinical Trial Agreements with Industry Sponsors
Full Text

Discipline: 

Subject: 

Publication: